An observational study in Healthy and Pregnant, sponsored by PT Bio Farma. Completed at 1 site in Indonesia. Open to female participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-06.
Sponsored by PT Bio Farma · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To assess any serious systemic reaction within 30 minutes after Td immunization in pregnant woman
Any local and systemic reaction after Td immunization in pregnant woman (as a routine immunization program)
PT Bio Farma is the lead sponsor of 47 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
200 pregnant woman, 18-39 years old From provincial health primary center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Any serious adverse event occurring from inclusion until 30 minutes after the injection
local and systemic reaction
Time frame: 30 minutes
Percentage of local and systemic events occurring within 72 hours after each injection
any local and systemics events
Time frame: 72 hours
Percentage of local and systemic events occurring from 72 hours up to 28 days following injection.
any local and systemics events
Time frame: 72 hours - 28 days
Percentage of serious adverse events within 28 days after injection
Any serious adverse events
Time frame: 28 days
Ran from Aug 2017 to primary completion in Jan 2018, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.